Month: September 2024
Sustained Sales Momentum in China in Q3 Following 37% Sequential Growth in Q2
Acquisition of SRx Health Remains On-Track
TAMPA, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it will present at the ThinkEquity Conference on October 30th, 2024 at the Mandarin Oriental Hotel in New York City. During the conference, management will provide updates on its international sales performance and the ongoing acquisition of SRx Health.
Key Highlights will Include:China Sales Growth: The Company continues to experience sales growth internationally, with sales from China increasing 37% sequentially for the second quarter of 2024 as compared to the first quarter of 2024. International sales account for approximately 28% of Better...
21Shares AG Announcement: 2024 Interim Financial Statements
Written by Customer Service on . Posted in Public Companies.
26 September 2024
Announcement: 2024 Interim Financial Statements
21Shares AG, the issuer of ETPs listed on various trading venues, has published its interim financial statements for the six months ending 30 June 2024. The financial statements are available at: https://21shares.com/ir/financials
Contact:
Email: press@21.co
Phone: +41 44 260 86 60
About 21Shares AG:
21Shares AG, Pelikanstrasse 37, 8001 Zurich, is a Swiss corporation registered in the commercial register of Zurich under the number CHE-347.562.100. It was incorporated on 27 July 2018 and its purpose is the issuance of Exchange Traded Products (ETPs) in Switzerland and worldwide.
Ninepoint Partners Announces Final September 2024 Cash Distribution for Ninepoint Cash Management Fund – ETF Series
Written by Customer Service on . Posted in Dividend Reports And Estimates.
TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the final September 2024 cash distribution for the Ninepoint Cash Management Fund – ETF Series. The record date for the distribution is September 27, 2024. This distribution is payable on October 7, 2024.
The per-unit final September distribution is detailed below:Ninepoint ETF Series
Ticker
Cash Distribution per unit
Notional Distribution per unit
CUSIPNinepoint Cash Management Fund
NSAV
$0.15667
$0.00000
65443X105About Ninepoint Partners
Based in Toronto, Ninepoint Partners LP is one of Canada’s leading alternative investment management firms overseeing approximately $7 billion in assets under management and institutional contracts. Committed to helping investors explore innovative investment solutions that have...
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
Written by Customer Service on . Posted in Public Companies.
REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent small molecules to treat and improve the lives of patients with metabolic diseases and genetically defined cancers, today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on Biomea’s ongoing Phase I/II clinical trials of the Company’s investigational covalent menin inhibitor BMF-219 in type 2 and type 1 diabetes (COVALENT-111 and COVALENT-112), respectively.
“We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for...
SCOR acquires Altarea’s stake in MRM. Following the acquisition, SCOR intends to file a simplified public tender offer
Written by Customer Service on . Posted in Public Companies.
Press releaseSeptember 26, 2024 – N° 13
SCOR acquires Altarea’s stake in MRM.Following the acquisition, SCOR intends to file a simplified public tender offer
To read this information in full, please confirm that you have read and understood the disclaimer on SCOR’s website here.
*
* *SCOR, a leading global reinsurer
As a leading global reinsurer, SCOR offers its clients a diversified and innovative range of reinsurance and insurance solutions and services to control and manage risk. Applying “The Art & Science of Risk”, SCOR uses its industry-recognized expertise and cutting-edge financial solutions to serve its clients and contribute to the welfare and resilience of society.
The Group generated premiums of EUR 19.4 billion in 2023 and serves clients in around 160 countries from its 35 offices worldwide.
For...
Healthcare costs at a post-pandemic high, US employers prioritize affordability and wellbeing
Written by Customer Service on . Posted in Public Companies.
Plan redesign outweighs cost-shifting to reduce the cost of care, WTW survey finds
NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) — As the cost of healthcare in the U.S. rises to a record high since the COVID-19 pandemic, nearly half of employers expect healthcare costs will exceed budget projections this year. In response, employers are embracing different approaches to safeguard program affordability for their companies as well as for their employees. While focusing on more competitive, cost-effective plan designs to control costs, they are seeking to maintain employee wellbeing, according to a new survey by WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company.
WTW’s 2024 Best Practices in Healthcare Survey found that U.S. employers project their healthcare costs will increase by 7.7% in 2025, compared with...
First Bank Announces Third Quarter 2024 Earnings Conference Call
Written by Customer Service on . Posted in Public Companies.
HAMILTON, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) — First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company’s financial and operating performance during its third quarter ending on September 30, 2024.Event:
Earnings Conference Call – Third Quarter 2024
When:
Thursday, October 24, 2024 at 9:00 a.m. Eastern Time
Access:
Conference Call Dial-In:
(800) 715-9871 (toll free)
Conference Call Access Code:
1578641
Patrick L. Ryan, President and Chief Executive Officer, Andrew L. Hibshman, Chief Financial Officer, Peter J. Cahill, Chief Lending Officer, and Darleen Gillespie, Chief Retail Banking Officer will provide an overview of third quarter 2024 results. The management presentation typically lasts approximately fifteen to thirty minutes, followed...
Proactis SA – announcement January 2024
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Proactis SA announces results for the 18 months period ended 31 January 2024
Paris – 26th September 2024 – Proactis SA (Euronext: PROAC), a leading provider of comprehensive spend management and business process collaboration solutions, today announced financial information for the year ended 31 January 2024, in accordance with the “European Transparency Obligations Directive” financial disclosure requirements.
It should be noted at the outset that publication of the results for the year ended January 31, 2024, was originally scheduled for May 31, 2024. Unfortunately, Proactis SA was unable to keep to this timetable, as its statutory auditors were unwilling to issue their reports on the accounts for the period just ended before the completion of the audit of the accounts of Proactis SA’s parent company by the group’s UK...
The 30-Year Fixed-Rate Mortgage Reaches Lowest Level in Two Years
Written by Customer Service on . Posted in Public Companies.
Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of 09/26/2024MCLEAN, Va., Sept. 26, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.08 percent.
“Although this week’s decline was slight, the 30-year fixed-rate mortgage trended down to its lowest level in two years,” said Sam Khater, Freddie Mac’s Chief Economist. “Given the downward trajectory of rates, refinance activity continues to pick up, creating opportunities for many homeowners to trim their monthly mortgage payment. Meanwhile, many looking to purchase a home are playing the waiting game to see if rates decrease further as additional economic data is released over the next several weeks.”
News FactsThe 30-year...
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update
Financial and business highlightsTotal H1 2024 incomes of €82.5 million thanks to Company’s new partnerships.
New strategic partnership with AbbVie for up to $713 million, including $48 million received upon signature.
Major partnership expansion with Boehringer Ingelheim:Amendment of the collaboration and licensing agreement on first-in-class SIRPα compounds developed both in immuno-oncology and now expected in Phase 2 in cardiovascular-renal-metabolic diseases: a one-time payment of €25.3 million.
New asset acquisition of a preclinical program from the OSE’s cis- targeting anti-PD1/cytokine platform: €13.5 million received upon signature and €17.5 potential near-term milestone.€8.4 million in non-dilutive funding under the “i-Démo” call...